Healthcare Equipment and Supplies
Company Overview of Capnia, Inc.
Capnia, Inc. develops and commercializes neonatology devices, diagnostics, and therapeutics platform based on its proprietary technology for precision metering of gas flow primarily in the United States. The company offers CoSense, an end-tidal carbon monoxide monitor, for the diagnosis of excessive hemolysis in neonates with jaundice, a condition that causes long-term developmental disability due to the degradation of red blood cells. It also develops Serenz, a therapeutic product candidate that has completed Phase II clinical trials for the treatment of symptoms related to allergic rhinitis. In addition, the company provides NeoPip T-piece resuscitator and related consumables, which delive...
1235 Radio Road
Redwood City, CA 94065
Founded in 1999
Key Executives for Capnia, Inc.
Chief Executive Officer, President and Director
Total Annual Compensation: $620.2K
Chief Financial Officer and Senior Vice President
Total Annual Compensation: $313.0K
Senior Vice President of Research and Development
Total Annual Compensation: $307.9K
Compensation as of Fiscal Year 2015.
Capnia, Inc. Key Developments
Capnia, Inc. Presents at Aegis Capital Corp. 2016 Growth Conference, Sep-21-2016 11:00 AM
Aug 24 16
Capnia, Inc. Presents at Aegis Capital Corp. 2016 Growth Conference, Sep-21-2016 11:00 AM. Venue: The Encore at Wynn Las Vegas, 3131 Las Vegas Blvd, Las Vegas, NV 89109, United States. Speakers: Anish Bhatnagar, Chief Executive Officer, President and Director.
Capnia, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2016
Aug 12 16
Capnia, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2016. For the quarter, the company reported product revenue of $391,000 against $97,000 a year ago. Operating loss was $3,450,000 against $3,044,000 a year ago. Net loss was $3,513,000 against profit of $1,881,000 a year ago. Basic and diluted net loss per common share was $0.23 against EPS of $0.25 a year ago.
For the six months, the company reported product revenue of $838,000 against $119,000 a year ago. Operating loss was $7,713,000 against $5,470,000 a year ago. Net loss was $6,702,000 against $9,770,000 a year ago. Basic and diluted net loss per common share was $0.44 against $1.35 a year ago.
Capnia, Inc., Special/Extraordinary Shareholders Meeting, Jul 29, 2016
Jul 18 16
Capnia, Inc., Special/Extraordinary Shareholders Meeting, Jul 29, 2016, at 08:30 Pacific Standard Time. Location: 1235 Radio Road Suite 110 Redwood City, CA 94065 California United States Agenda: To approve the issuance of up to an aggregate of 16,602,704 shares of common stock.
Similar Private Companies By Industry
Recent Private Companies Transactions
June 29, 2016
October 12, 2015